Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus ClopidogrelJacob A. Doll, Keith A.A. Fox, Megan L. Neely et al.|Journal of the American College of Cardiology|2016Cited by 39
Intensive Care Unit Utilization and Mortality Among Medicare Patients Hospitalized With Non–ST-Segment Elevation Myocardial InfarctionAlexander C. Fanaroff, Tracy Y. Wang, Eric D. Peterson et al.|JAMA Cardiology|2016Cited by 39
Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary InterventionJacob A. Doll, Sunil V. Rao, Dadi Dai et al.|JACC: Cardiovascular Interventions|2017Cited by 22
THE ASSOCIATION OF P2Y12 INHIBITOR COPAYMENT REDUCTION WITH OUTCOMES AT HOSPITALS WITH AND WITHOUT MEDICATION ASSISTANCE PROGRAMSJacob A. Doll, Tracy Wang, Eileen Fonseca et al.|Journal of the American College of Cardiology|2019Cited by 0